TCI Wealth Advisors’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-735
Closed -$14.3K 878
2023
Q1
$14.3K Buy
735
+181
+33% +$3.15K ﹤0.01% 878
2022
Q4
$8.89K Sell
554
-290
-34% -$4.73K ﹤0.01% 1147
2022
Q3
$13K Buy
+844
New +$16.3K ﹤0.01% 862
2020
Q1
Sell
-100
Closed -$2K 1554
2019
Q4
$2K Hold
100
﹤0.01% 1136
2019
Q3
$2K Sell
100
-100
-50% -$2.02K ﹤0.01% 1070
2019
Q2
$4K Hold
200
﹤0.01% 813
2019
Q1
$5K Hold
200
﹤0.01% 783
2018
Q4
$4K Hold
200
﹤0.01% 816
2018
Q3
$4K Buy
200
+100
+100% +$1.95K ﹤0.01% 840
2018
Q2
$2K Buy
+100
New +$2.07K ﹤0.01% 1067

Other funds holding EXEL

TCI Wealth Advisors's EXEL Position: Q2 2023 in Review

TCI Wealth Advisors sold out of Exelixis (EXEL) in Q2 2023, closing a stake of 735 shares — an estimated $14.3K sold.

TCI Wealth Advisors first reported a position in EXEL in Q2 2018 and held it in 10 quarters. The position peaked at $14.3K in Q1 2023. 378 funds tracked by Wall St. Rank hold EXEL as of Q2 2023.

  • TCI Wealth Advisors reported no remaining Exelixis position as of Q2 2023 after selling out during the quarter.
  • TCI Wealth Advisors sold 735 Exelixis shares in Q2 2023, an estimated $14.3K.
  • TCI Wealth Advisors first reported a position in Exelixis in Q2 2018 and held it in 10 quarters.
  • TCI Wealth Advisors's Exelixis position peaked at $14.3K in Q1 2023.
  • 378 funds tracked by Wall St. Rank held Exelixis as of Q2 2023.

Based on TCI Wealth Advisors's 13F filing for Q2 2023, filed 4 Aug 2023.